
GLAXOGlaxosmithkline Pharmaceuticals Ltd.
Glaxosmithkline Pharmaceuticals Q2 FY27 Results: Consolidated Net Profit ₹336 Crore on Total Income of ₹1,256 Crore
Glaxosmithkline Pharmaceuticals (NSE: GLAXO) reported consolidated total income of ₹1,256 crore and net profit of ₹336 crore for the quarter ended 30 Sep 2026, it said in a filing on 03 Nov 2026. Standalone total income was ₹1,253 crore and net profit ₹335 crore.
- Earnings
- pharmaceuticals